• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在戈林综合征中观察到的5%咪喹莫特乳膏用于治疗基底细胞癌的情况。

The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.

作者信息

Micali G, Lacarrubba F, Nasca M R, De Pasquale R

机构信息

Dermatology Clinic, University of Catania, Catania, Italy.

出版信息

Clin Exp Dermatol. 2003 Nov;28 Suppl 1:19-23. doi: 10.1046/j.1365-2230.28.s1.7.x.

DOI:10.1046/j.1365-2230.28.s1.7.x
PMID:14616807
Abstract

Gorlin's syndrome (naevoid basal cell carcinoma) is an autosomal dominant tumour-predisposition syndrome. It typically consists of multiple basal cell carcinomas (BCCs) of the skin, odontogenic keratocysts of the jaw, various skeletal abnormalities and lamellar falx calcifications. Four patients with multiple facial and trunk BCCs (superficial and nodular) consistent with Gorlin's syndrome are reported. Imiquimod 5% cream was topically applied to the lesions 3-5 times a week for 8-14 weeks. Two of the patients suffered mild to severe erythema and developed superficial erosions but did not discontinue treatment. Imiquimod 5% cream successfully treated 13 out of 17 BCCs in these patients with Gorlin's syndrome, with no patient suffering a relapse at the follow-up visit.

摘要

戈林综合征(痣样基底细胞癌综合征)是一种常染色体显性肿瘤易感综合征。它通常表现为皮肤多发性基底细胞癌(BCC)、颌骨牙源性角化囊肿、各种骨骼异常以及板层状大脑镰钙化。本文报告了4例符合戈林综合征的面部和躯干多发性BCC(浅表性和结节性)患者。每周3 - 5次在皮损处外用5%咪喹莫特乳膏,持续8 - 14周。2例患者出现轻至重度红斑并形成浅表糜烂,但未中断治疗。5%咪喹莫特乳膏成功治疗了这些戈林综合征患者17处BCC中的13处,随访时无患者复发。

相似文献

1
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.在戈林综合征中观察到的5%咪喹莫特乳膏用于治疗基底细胞癌的情况。
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:19-23. doi: 10.1046/j.1365-2230.28.s1.7.x.
2
The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.5%咪喹莫特乳膏用于基底细胞痣综合征患者浅表性基底细胞癌的治疗。
Dermatol Surg. 2000 Jun;26(6):577-8; discussion 578-9. doi: 10.1046/j.1524-4725.2000.00003.x.
3
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes.咪喹莫特反应性基底细胞癌与富含因子 XIIIa 的树突状细胞。
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:27-9. doi: 10.1046/j.1365-2230.28.s1.9.x.
4
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients.用免疫反应调节剂治疗的浅表性和结节性基底细胞癌:7例患者的报告。
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:24-6. doi: 10.1046/j.1365-2230.28.s1.8.x.
5
Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.咪喹莫特 5%乳膏预处理面部结节状基底细胞癌的 Mohs 显微外科手术:一项前瞻性随机对照研究。
Br J Dermatol. 2012 Jul;167(1):110-5. doi: 10.1111/j.1365-2133.2012.10924.x. Epub 2012 May 21.
6
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.咪喹莫特局部治疗基底细胞痣综合征患者的浅表性和结节性基底细胞癌:初步报告。
J Dermatolog Treat. 2002 Sep;13(3):123-7. doi: 10.1080/09546630260199488.
7
Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream.用5%咪喹莫特乳膏治疗面部浅表性基底细胞癌。
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:16-8. doi: 10.1046/j.1365-2230.28.s1.6.x.
8
Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.外用5%咪喹莫特成功治疗痣样基底细胞癌综合征中的基底细胞癌
Eur J Dermatol. 2002 Nov-Dec;12(6):569-72.
9
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.咪喹莫特治疗浅表性和结节性基底细胞癌:12周开放标签试验。
Dermatol Surg. 2005 Mar;31(3):318-23. doi: 10.1111/j.1524-4725.2005.31081.
10
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.5%咪喹莫特乳膏治疗面部基底细胞癌:一项3年回顾性随访研究
Australas J Dermatol. 2006 Aug;47(3):169-71. doi: 10.1111/j.1440-0960.2006.00265.x.

引用本文的文献

1
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.基底细胞癌:当代诊断与治疗的叙述性综述
Oncol Ther. 2022 Dec;10(2):317-335. doi: 10.1007/s40487-022-00201-8. Epub 2022 Jun 21.
2
Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI).非黑色素瘤皮肤癌管理的综合护理路径与中心辐射模式:意大利医院皮肤科医生协会(ADOI)的提议
Dermatol Reports. 2021 Aug 5;13(2):9278. doi: 10.4081/dr.2021.9278. eCollection 2021 Aug 1.
3
Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
基底细胞癌:从病理生理学到新型治疗方法
Biomedicines. 2020 Oct 23;8(11):449. doi: 10.3390/biomedicines8110449.
4
Imiquimod - Its role in the treatment of cutaneous malignancies.咪喹莫特——其在皮肤恶性肿瘤治疗中的作用。
Indian J Pharmacol. 2015 Jul-Aug;47(4):354-9. doi: 10.4103/0253-7613.161249.
5
Management of superficial basal cell carcinoma: focus on imiquimod.浅表基底细胞癌的治疗管理:聚焦咪喹莫特。
Clin Cosmet Investig Dermatol. 2009 Jun 11;2:65-75. doi: 10.2147/ccid.s3507.
6
Nevoid basal cell carcinoma syndrome (Gorlin syndrome).痣样基底细胞癌综合征(戈林综合征)。
Orphanet J Rare Dis. 2008 Nov 25;3:32. doi: 10.1186/1750-1172-3-32.
7
Advances in the use of topical imiquimod to treat dermatologic disorders.局部用咪喹莫特治疗皮肤疾病的新进展。
Ther Clin Risk Manag. 2008 Feb;4(1):87-97. doi: 10.2147/tcrm.s1109.